The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis.
about
Structural basis for vitamin D receptor agonism by novel non-secosteroidal ligandsCellulite: Is there a role for injectables?Copper regulates cyclic-AMP-dependent lipolysisPivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts.Phospholipase C-related catalytically inactive protein (PRIP) regulates lipolysis in adipose tissue by modulating the phosphorylation of hormone-sensitive lipase.The Structural Basis of Action of Vanadyl (VO(2+)) Chelates in Cells.Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP.Metabolic effects of newly synthesized phosphodiesterase-3 inhibitor 6-[4-(4-methylpiperidin-1-yl)-4-oxobutoxy]-4-methylquinolin-2(1H)-one on rat adipocytes.Chronic ethanol feeding suppresses beta-adrenergic receptor-stimulated lipolysis in adipocytes isolated from epididymal fat.Alterations in cyclic nucleotide phosphodiesterase activities in omental and subcutaneous adipose tissues in human obesity.The Role of PDE3B Phosphorylation in the Inhibition of Lipolysis by Insulin.Studying lipolysis in adipocytes by combining siRNA knockdown and adenovirus-mediated overexpression approaches.Flavonoids attenuate cardiovascular disease, inhibit phosphodiesterase, and modulate lipid homeostasis in adipose tissue and liver.PDE3 and PDE4 isozyme-selective inhibitors are both required for synergistic activation of brown adipose tissue.Amino acid-sensing mTOR signaling is involved in modulation of lipolysis by chronic insulin treatment in adipocytesReduced adiposity and high-fat diet-induced adipose inflammation in mice deficient for phosphodiesterase 4B.Roflumilast and aquaporin-2 regulation in rat renal inner medullary collecting duct.Clinical and molecular genetics of the phosphodiesterases (PDEs).Control of lipid storage and cell size between adipocytes by vesicle-associated glycosylphosphatidylinositol-anchored proteins.Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.Temporal and spatial regulation of cAMP signaling in disease: role of cyclic nucleotide phosphodiesterases.Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson's Disease?The role of mouse Akt2 in insulin-dependent suppression of adipocyte lipolysis in vivoExpression of Recombinant Phosphodiesterases 3A and 3B Using Baculovirus Expression System.mRNA expression and antilipolytic role of phosphodiesterase 4 in rat adipocytes in vitro.The effects of forskolin and rolipram on cAMP, cGMP and free fatty acid levels in diet induced obesity.Reduced PDE4 expression and activity contributes to enhanced catecholamine-induced cAMP accumulation in adipocytes from FOXC2 transgenic mice
P2860
Q27684118-C0C56A2D-8A3E-43C5-8971-A3E8483D4949Q29035649-D52EEE84-1C10-460C-9842-BF244887F70FQ30787648-7B0D16BB-B522-40F1-AB8B-E3430C6E38B5Q33552229-384528BE-2357-4939-9EA5-2BEAA50ED408Q33779895-037ECD6B-43E2-4A1D-9AF7-231B701F7E08Q34180436-E62EE97D-30E6-4096-8EDF-5D3896359C59Q34720827-8A5C012E-214E-4EF6-A1F4-D27E31ED3C78Q35165079-8D9A11C1-F353-406D-A7AB-467D903F2491Q35574446-58E25EF0-1AFF-4C83-B601-E7101E25A0A7Q35825801-F9DF87FA-5338-45E9-8699-3801D12DF356Q35868387-63D17541-E1E2-4554-AEF5-3C1819689700Q35928761-AE7E64B6-349D-4AB0-B4FB-B8D9963AFC7BQ36583262-F54232B0-3688-4B4B-BF50-7BEFBF0FE1C7Q36852544-67516898-6D66-4D9C-A055-C5A4EDEBBDA2Q37162256-005903A1-1A7A-480A-A0D3-CCE340CEF99FQ37244563-DA56104F-89F0-4EFA-BB94-AC5DF6BF7905Q37609062-50B5CF99-8376-4943-9E44-7193471CC3EFQ37657841-FF586D5E-13EE-45D9-8CD8-4240080638EDQ37794985-24C6E866-D3FE-433F-86BF-76A555542519Q37947681-3D9D4A76-3803-454A-9CCB-7E74287D84C0Q38205932-C50919B7-F22A-484F-B397-F7A6D7D1BA6AQ39072124-8629E8D6-F2A5-425E-84A2-7C1BB7604FD3Q39530992-B90624B0-4A84-4390-8FA0-ADD3F4018601Q41674079-A6911347-B2FF-48BC-90B8-4B50D9021EAFQ42507723-8FA4D946-E3FA-4D96-9CC1-2D295DB06014Q51161336-260A3B63-29A7-48BD-8CD8-6BCD8CFE92EAQ57910591-0D7E4B5C-A485-4410-82AA-2E1B38AE8DC4
P2860
The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The role of cyclic nucleotide ...... lation of adipocyte lipolysis.
@en
The role of cyclic nucleotide ...... lation of adipocyte lipolysis.
@nl
type
label
The role of cyclic nucleotide ...... lation of adipocyte lipolysis.
@en
The role of cyclic nucleotide ...... lation of adipocyte lipolysis.
@nl
prefLabel
The role of cyclic nucleotide ...... lation of adipocyte lipolysis.
@en
The role of cyclic nucleotide ...... lation of adipocyte lipolysis.
@nl
P2093
P2860
P1476
The role of cyclic nucleotide ...... lation of adipocyte lipolysis.
@en
P2093
James M Esselstyn
Kate Loughney
Peter B Snyder
Sharon L Wolda
Vincent A Florio
P2860
P304
P356
10.1194/JLR.M400362-JLR200
P577
2004-12-16T00:00:00Z